Navigation Links
Palatin Technologies, Inc. Announces Positive Safety Results in Subcutaneous Bremelanotide Trial in Men
Date:8/17/2010

CRANBURY, N.J., Aug. 17 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) today announced positive results of a Phase 1 clinical trial of subcutaneously administered bremelanotide, its melanocortin agonist drug candidate for treatment of male erectile dysfunction (ED) and female sexual dysfunction (FSD). The results demonstrate that with subcutaneous administration consistent therapeutic blood plasma levels can be obtained without sustained clinically significant blood pressure effects and support the continued development of bremelanotide.

As part of the analysis of the effects of bremelanotide on blood pressure, the Company engaged an independent panel of cardiovascular experts to evaluate both study results and an integrated cardiovascular safety analysis conducted on data from completed bremelanotide studies. Based on recommendations from the outside panel and its own internal review, Palatin intends to engage the Food and Drug Administration (FDA) in discussions regarding clinical trial designs to further study bremelanotide for the treatment of sexual dysfunction.

Palatin expects to meet with the FDA in the fourth quarter of calendar year 2010 to discuss initiation of a Phase 2 study of subcutaneously administered bremelanotide, as a monotherapy and as a combination therapy with a PDE-5 inhibitor such as sildenafil (Viagra®), for men with ED who are not responsive or inadequately responsive to PDE-5 inhibitor therapies alone.  

The objective of the placebo-controlled, randomized, double-blind, cross over safety study was evaluation of blood pressure effects of subcutaneous bremelanotide in healthy male volunteers between 45 and 65 years old.  The study also evaluated dose-to-dose consistency of plasma exposure of bremelanotide.  A total of 49 subjects were dosed in the safety study; nineteen of the subjects were enro
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
2. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
3. Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994
4. Palatin Technologies Presents PL-3994 Clinical Trial Results at the 12th Annual Scientific Meeting of the Heart Failure Association of America
5. Palatin Technologies to Present at 8th Annual BIO Investor Forum
6. Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men
7. Palatin Technologies, Inc. To Raise $2.6 Million Dollars in Registered Direct Offering
8. Palatin Technologies, Inc. Receives $2.5 Million from AstraZeneca
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Oregon , October 22, 2014 ... "Global Disposable Gloves Market (Product type, Form, End user, ... Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and ... global disposable gloves market. Based on key trends tracked, ... be valued at $7.9 billion by 2020, registering a ...
(Date:10/22/2014)... 22, 2014  With a vision to ensure ... a Global Pharmaceutical and Biotech manufacturer selects and ... turnkey solution to protect their animal health brand.  ... Photo - http://photos.prnewswire.com/prnh/20141021/153439 ... and aggregated by the Xyntek and Antares solution ...
(Date:10/22/2014)... DIEGO , Oct. 21, 2014   ... today the latest genomics research centers to purchase ... Salk Institute, the National Cancer Institute (NCI), NIH ... Sequencing Center). Before Irys, obtaining a comprehensive view ... next generation sequencing (NGS) does not deliver the ...
Breaking Medicine Technology:Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 4Xyntek and Antares Serialization Solution Protects Pets Too! 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3
(Date:10/22/2014)... For Dr. Iris Hunter, a job is ... extension of her life’s mission. Her extensive experience in the ... of FirstLight HomeCare, make it clear that Hunter’s mission is ... my work makes a difference in the lives of others,” ... after much research, I felt ready to start on this ...
(Date:10/22/2014)... Hay House is pleased to announce the official ... Life (Paperback; $10.82) written by the highly esteemed Tommy Rosen, ... book is meant to help readers of all kinds end ... , Recovery 2.0 is not the average self-help book, or ... guide for what comes next. For many, Alcoholics ...
(Date:10/22/2014)... October 22, 2014 Losing Weight Your Body’s ... is staring you in the face, it certainly can be ... do your body an extra favor by doing it the ... crash diets. Instead, listen to your body, exercise regularly, and ... is essential to losing weight; you need to exercise more ...
(Date:10/22/2014)... Steven Reinberg HealthDay ... Infants who quickly add weight and length may be showing ... suggests. In adults, certain genes have been linked to ... proportionate gains in fat and lean muscle, the researchers said. ... heavier and taller. By ages 2 and 3, however, these ...
(Date:10/22/2014)... TUESDAY, Oct. 21, 2014 (HealthDay News) -- Measures taken ... plantation in Ebola-ravaged Liberia may have limited the spread ... researchers report. The Firestone Natural Rubber Co. provides ... and residents of nearby densely populated communities. Between ... and suspected Ebola cases among those 80,000 people. That ...
Breaking Medicine News(10 mins):Health News:Dr. Iris Hunter to Host Grand Opening of FirstLight HomeCare Tomorrow 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3Health News:ReductionGuruMD Presents Ways to Improve Your Weight Loss Results 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2
... ... Environmental Protection Agency has designated January as National Radon Action Month. ... is responsible for approximately 20,000 deaths in the U.S. and 100,000 ... lung cancer deaths.  Statistically, radon is the leading cause of lung ...
... ... portal for background checks to their long list of services. ANY LAB TEST ... screens and STD tests to Dallas residents. , ... Dallas, TX (Vocus) January 12, 2009 -- ANY LAB TEST NOW® North Dallas announces web ...
... In mice, even small amount of amyloid plaques affected olfactory ... in mice suggests that loss of smell could serve as ... are already known to suffer from loss of smell. But ... amyloid plaques -- the bits of gunk in the brain ...
... Jan. 12 For singer / songwriter Lisa Nemzo the ... Colatrella , who is dying of cancer, uncovered a healthcare madness ... system is broken and out of control. "Even a basic timely ... helped arrest Artie,s cancer just didn,t reach him in time. Artie,s ...
... WASHINGTON , Jan. 12 The Lupus Foundation ... Gina M. Finzi Memorial Student Summer Fellowship Program.  The purpose ... investigators in lupus research under the supervision of an established ... however, preference is given to students with a college degree. ...
... HARRISBURG, Pa. , Jan. 12 Capital BlueCross is ... of have been resolved for former Turbine Airfoil Designs (TAD) employees ... its premiums and subsequently went out of business. , Last ... paying its health insurance premiums since October, and that their coverage ...
Cached Medicine News:Health News:Radon Gas Identified as America's Leading In-Home Killer; EPA Takes Action to Prevent 20,000 U.S. Cancer Deaths Each Year 2Health News:Radon Gas Identified as America's Leading In-Home Killer; EPA Takes Action to Prevent 20,000 U.S. Cancer Deaths Each Year 3Health News:ANY LAB TEST NOW North Dallas Launches Web Portal for Background Checks 2Health News:Singer / Songwriter Creates Video to Save Friend's Life 2Health News:The Lupus Foundation of America Seeks Applications for its 2010 Gina M. Finzi Memorial Student Summer Fellowship Program 2Health News:The Lupus Foundation of America Seeks Applications for its 2010 Gina M. Finzi Memorial Student Summer Fellowship Program 3Health News:Capital BlueCross and Local Providers Reach Solution for Health Care Claims of Former Turbine Airfoil Designs Employees 2
Ideal for surgical procedures, these portable stands fit into tight areas for easy instrument access. Easy placement over patient....
... Illuminated membrane switch control, solid cast ... Single button folding armrests, multi-position full ... brake with handle, ergonomically contoured cushions ... bushings, choice of upholstery colors. Optional ...
... quality, new 8" Swiss-made ... capacity, smooth operation, footswitch ... in any Topcon upholstery ... Optional features: 90 Degree ...
... chair for examination of the ... adjustable from 540 mm to ... an independent foot switch. The ... and incorporates a multi-adjustable headrest, ...
Medicine Products: